Pharmaceutical wholesaling strategy

Alliance Healthcare is one of Europe’s largest pharmaceutical wholesalers with an excellent reputation for service and reliability.

Our strategy for Alliance Healthcare is to be the world’s best  wholesaler and distributor of pharmaceutical products, working in partnership to provide added-value services for pharmacy and manufacturer customers.

The key steps we are taking to execute our strategy include:

Ensuring that we continue to deliver an excellent core service to all our customers.  Typically we deliver prescription medicines to pharmacies at least twice a day on a just-in-time basis to meet patients’ needs.  In stock availability, accuracy of picking and reliable van deliveries within set time periods are essential to achieving this consistently.  

Evolving our business model to meet changing demands from manufacturer and pharmacy customers for new services.  We aim to do this through achieving preferred status for selective wholesaler contracts, winning direct-to-pharmacy distribution contracts, expanding our pre-wholesale and contract logistics services, developing our contract sales forces, and developing innovative added-value services such as the Alphega Pharmacy concept.  We continue to develop other new solutions to meet customers’ evolving needs.

Increasing efficiency and driving down costs by growing market share where it is desirable to do so, completing our Division-wide business improvement programme and acquiring businesses to increase scale.

Differentiating our product offering.  We are achieving this through a series of initiatives which include the development of Almus, our exclusive range of generic medicines, and the extension of Alvita, our branded patient care product range.  In addition, we are increasing the number of European countries in which our Boots Laboratories Serum7 skincare range is sold to independent pharmacies.  

Extending our capabilities into high growth specialty medicine/homecare markets and entering new geographical markets where stable regulatory environments, large populations, growing healthcare expenditure, scope for wholesaler consolidation and the right management can be found, such as in Russia and China in recent years.